Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In recent years, there has been mounting evidence to support the presence of stem and progenitor cells within many adult tissues that retain the capacity to proliferate and differentiate, thereby contributing to tissue homeostasis and repair. In line with these discoveries, there have been increasing efforts to develop new agents that target these resident stem and progenitor cell populations in situ to augment or to stimulate repair and regeneration processes. Two such agents are approved drugs, and several more are currently in clinical and preclinical development. Through this emerging therapeutic paradigm there is enormous scope for medicinal chemistry to play a pivotal role in regenerative medicine. The potential impact of regenerative medicinal chemistry is profound, and future studies will reveal which tissue types or disease states will prove most readily tractable through this approach.

Original publication




Journal article


ACS Med Chem Lett

Publication Date





365 - 368